Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells

ChEBI2011-06-16 更新2026-07-21 收录

下载链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-29873

下载链接

链接失效反馈

官方服务：

资源简介：

Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells

创建时间：

2011-06-16

Regulatory Enhancer Profiling of Mesenchymal-type Gastric Cancer Reveals Subtype-Specific Epigenomic Landscapes and Targetable Vulnerabilities. Regulatory Enhancer Profiling of Mesenchymal-type Gastric Cancer Reveals Subtype-Specific Epigenomic Landscapes and Targetable Vulnerabilities

Recent studies have highlighted mesenchymal-subtype GC (Mes-GC) as a clinically aggressive subtype with few treatment options. Genome-wide chromatin profiles of primary GCs and GC cell lines were gene

NIAID Data Ecosystem170

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024

Global induced pluripotent stem cell (ipsc) market size is expected to reach $4.81 Bn by 2028 at a rate of 10.0%, segmented as by derived cell type, hepatocytes, fibroblasts, keratinocytes, amniotic c

www.thebusinessresearchcompany.com130

H3K27me3 in human bladder transitional cell carcinoma cell line CL1207

The H3K27me3 ChIP-seq data for the human bladder transitional cell carcinoma cell line CL1207 were generated in order to detect regions of regional epigenetic silencing in this cell line and test the

NIAID Data Ecosystem110

Methylation array of upper urinary tract urothelial carcinoma

Genome-wide methylation analysis of upper urinary tract urothelial carcinoma using Infinium MethylationEPIC BeadChip KitEGA dataset EGAD00010002096

NIAID Data Ecosystem150

Additional file 9: of Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

SE_MCF7_H3K27Ac_ER. (XLS 87 kb)

NIAID Data Ecosystem130